Anacor Pharmaceuticals, Inc.

CIK 1411158 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Anacor Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Jul 11, 2016SC 13G/A0000315066-16-006001
Jul 11, 2016SC 13G/A0001144204-16-112431
Jul 5, 201615-12B0001193125-16-641683
Jun 29, 2016EFFECT9999999995-16-005021
Jun 29, 2016EFFECT9999999995-16-005022
Jun 29, 2016EFFECT9999999995-16-005023
Jun 29, 2016EFFECT9999999995-16-005024
Jun 24, 2016POS AM0001193125-16-630893
Jun 24, 2016POS AM0001193125-16-630889
Jun 24, 20168-K0001193125-16-630877
Jun 24, 201640000950103-16-014339
Jun 24, 2016POS AM0001193125-16-630894
Jun 24, 2016S-8 POS0001193125-16-630900
Jun 24, 201640000950103-16-014332
Jun 24, 2016S-8 POS0001193125-16-630898
Jun 24, 2016S-8 POS0001193125-16-630902
Jun 24, 201625-NSE0001354457-16-000405
Jun 24, 201640000950103-16-014336
Jun 24, 2016S-8 POS0001193125-16-630905
Jun 24, 201640000950103-16-014335
Jun 24, 201640000950103-16-014337
Jun 24, 201640000950103-16-014342
Jun 24, 201640000950103-16-014331
Jun 24, 2016POS AM0001193125-16-630892
Jun 24, 201640000950103-16-014340